Biolegend, 110728, PerCP/Cyanine5.5 anti-mouse CD45.1 Antibody
100microg
Catalog Number: 110728
Loading…
| Verified Reactivity | Mouse |
|---|---|
| Antibody Type | Monoclonal |
| Host Species | Mouse |
| Immunogen | SJL mouse thymocytes and splenocytes |
| Formulation | Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide. |
| Preparation | The antibody was purified by affinity chromatography, and conjugated with PerCP/Cyanine5.5 under optimal conditions. |
| Concentration | 0.2 mg/ml |
| Storage & Handling | The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze. |
| Application | FC - Quality tested |
| Recommended Usage | Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application. * PerCP/Cyanine5.5 has a maximum absorption of 482 nm and a maximum emission of 690 nm. |
| Excitation Laser | Blue Laser (488 nm) |
Unless otherwise stated, the minimum order amount is USD 1,000.
For orders below USD 1,000, an additional handling fee may apply, or we may arrange local delivery / local handover where available.
All quotations are subject to final confirmation, including product availability, lead time, batch information, shipping cost, and applicable export or handling requirements.
For quotation requests, please send an RFQ from website or contact:
Please send inquiries directly to us in the “To” field. Emails sent via BCC, mass mailing, or with unrelated recipients may be automatically filtered and will not be processed.
| Application Notes |
|---|
| The A20 antibody does not react with leukocytes or mouse cells expressing the CD45.2 alloantigen. Additional reported applications (for relevant formats of this clone) include: immunoprecipitation3, in vitro blocking of B cell responses1,2, immunohistochemical staining of frozen sections: OCT embedded7 and acetone-fixed4-6 (direct immunofluorescence detection with fluorochrome conjugated A20 was used in (5) and (6)). |
| Application References(PubMed link indicates BioLegend citation) | Yakura H, et al. 1983. J. Exp. Med. 157:1077. (Block) Yakura H, et al. 1986. J. Immunol. 136:2729. (Block) Shen FW, et al. 1986. Immunogenetics 24:146. (IP) Suzuki K, et al. 2000. Immunity 13:691. (IHC-F) Werner N, et al. 2002. Arterioscler. Thromb. Vasc. Biol. 22:1567. (IHC-F) Lessner SM, et al. 2002. Am. J. Pathol. 160:2145. (FC, IHC-F) Chen CC, et al. 2005. P. Natl. Acad. Sci. USA 102:11408 (IHC-F) Pascal V, et al. 2007. J. Immunol. 179:1751. (FC) Mende I, et al. 2006. Blood 107:1383. (IHC-F, FC) Phan TG, et al. 2007. Nature Immunol. 8:992. (FC) Wither DR, et al. 2009. J. Immunol. 183:5079. PubMed Pascal V, et al.2007. J. Immunol. 179:1751. PubMed Lee SW, et al. 2009. J. Immunol. 182:6753. PubMed Takada K, et al. 2009. J. Exp Med. 206:2253. PubMed Beamer CA, et al. 2007. Am. J. Respir. Cell. Mol. Biol. 37:729. (FC) PubMed Li LX, et al. 2010. J. Immunol. 184:1728. PubMed Hosoi A, et al. 2008. Cancer Res. 68:3941. (FC) PubMed Kenna TJ, et al. 2008. Blood 111:2091. PubMed Kohlmeier JE, et al. 2008. Immunity. 29:101. (FC) PubMed |
|---|
| Product Citations | Hirai T, et al. 2020. Immunity. 54(1):84-98.e5. PubMed Tas JMJ, et al. 2022. Immunity. 55:1856. PubMed Melzi E, et al. 2022. Immunity. 55:2168. PubMed Russler-Germain EV, et al. 2021. Immunity. 54:2547. PubMed Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed Wang Y, et al. 2022. Cell Rep. 41:111738. PubMed Pleuger C, et al. 2022. Elife. 11: . PubMed Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed Li X, et al. 2022. Cell. 185:1709. PubMed Reticker-Flynn NE, et al. 2022. Cell. 185:1924. PubMed Wang L, et al. 2019. Cell Rep. 29:1848. PubMed Xia S, et al. 2014. J Leukoc Biol. 95:733. PubMed Turner JS et al. 2018. Cell reports. 25(6):1395-1403 . PubMed Stewart I et al. 2018. Immunity. 49(3):477-489 . PubMed Sangesland M, et al. 2020. Immunity. 51(4):735-749. PubMed Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed Hirano KI, et al. 2021. eLife. 0.416666666666667. PubMed Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed Liang Y, et al. 2020. J Immunol. 204:2984. PubMed Fuster JJ, et al. 2020. Cell Rep. 33:108326. PubMed Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed Inoue D, et al. 2021. Nat Genet. 53:707. PubMed Zong L, et al. 2021. NPJ Aging Mech Dis. 7:25. PubMed Yang W, et al. 2020. Mucosal Immunol. 13:788. PubMed Marangoni F, et al. 2021. Cell. . PubMed Yoshimi A, et al. 2019. Nature. 574:273. PubMed Beauchamp EM, et al. 2021. Blood Cancer Discov. 6:. PubMed Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed Kim C, et al. 2019. Cell Rep. 29:2202. PubMed Glaros V, et al. 2021. Immunity. 54:2005. PubMed Bayik D, et al. 2020. Cancer Discov. 1.256944444. PubMed Quah B, et al. 2012. Cytometry A. 81:679. PubMed Karimi M, et al. 2015. Blood. 125:3655. PubMed Platteel A, et al. 2017. Vaccine.. 10.1016/j.vaccine.2017.10.044. PubMed Marcus A et al. 2018. Immunity. 49(4):754-763 . PubMed Krueger CC, et al. 2019. Front Immunol. 10:1831. PubMed Sharma S, et al. 2021. Pathophysiology. 28:501. PubMed Lim JE, et al. 2022. Front Oncol. 12:1045016. PubMed Murakami K, et al. 2021. Cell Reports. 34(1):108579. PubMed Huang D, et al. 2020. Nat Commun. 4.520833333. PubMed LM S, et al. 2016. Cell Rep. 16(12): 3286-96. PubMed Moutuou MM, et al. 2020. Methods Mol Biol. 2111:267. PubMed Evgin L, et al. 2020. Nat Commun. 2.671527778. PubMed Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed Suan D et al. 2017. Immunity. 47(6):1142-1153 . PubMed Kretschmer L, et al. 2020. Nat Commun. 0.536805556. PubMed Ma K, et al. 2022. iScience. 25:104347. PubMed Wang X, et al. 2021. EMBO J. 40:e105926. PubMed Yuan X, et al. 2017. Elife. 6:e29540. PubMed Lee SC et al. 2018. Cancer cell. 34(2):225-241 . PubMed Lamb T, et al. 2022. Toxics. 10:. PubMed Zeis P, et al. 2020. Immunity. 53:775. PubMed X X, et al. 2016. J Immunol . 197: 1683-1691. PubMed Muri J, et al. 2020. Cell Reports. 29(9):2731-2744.e4.. PubMed Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed Zhu YP et al. 2018. Cell reports. 24(9):2329-2341 . PubMed Di Pilato M, et al. 2021. Cell. 184(17):4512-4530.e22. PubMed Mujal AM, et al. 2022. Cancer Immunol Res. 10:403. PubMed Gundra UM, et al. 2017. Nat Immunol. 1.195833333. PubMed Ehrens A, et al. 2021. Cell Reports. 34(2):108621. PubMed |
|---|
| RRID | AB_893348 (BioLegend Cat. No. 110727) AB_893346 (BioLegend Cat. No. 110728) |
|---|
| Structure | Protein tyrosine phosphatase (PTP) family, 180-240 kD |
|---|
| Distribution | All hematopoietic cells except mature erythrocytes and platelets of the CD45.1 strain of mice |
|---|
| Function | Phosphatase, T and B cell activation |
|---|
| Ligand/Receptor | Galectin-1, CD2, CD3, CD4 |
|---|
| Biology Area | Cell Biology, Immunology, Inhibitory Molecules, Neuroscience, Neuroscience Cell Markers |
|---|
| Molecular Family | CD Molecules |
|---|
| Antigen References | 1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press. 2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85. 3. Kishihara K, et al. 1993. Cell 74:143. 4. Pulido R, et al. 1988. J. Immunol. 140:3851. |
|---|
| Gene ID | 19264 |
|---|
| UniProt | View information about CD45.1 on UniProt.org |
|---|
| Clone | A20 |
|---|
| Regulatory Status | RUO |
|---|
| Other Names | T200, Ly-5.1, LCA |
|---|
| Isotype | Mouse (A.SW) IgG2a, κ |
|---|
